Creative Biolabs provides small molecule process development and optimization, quantifying synthetic yields and purity profiles. We offer route scouting and scale-up to evaluate manufacturing feasibility.
Creative Biolabs offers a comprehensive suite of CMC solutions that bridge the critical gap between early candidate selection and large-scale commercialization. We resolve the inherent friction between aggressive development timelines and rigorous quality requirements by providing the robust technical data and reliable material supply necessary for successful regulatory filings. Our multidisciplinary approach ensures that the chemical development of the drug substance (DS) is perfectly aligned with the pharmaceutical development of the drug product (DP), preventing the costly "re-work" phases that often plague non-integrated development models.
CMC constitutes the scientific heart of any drug application, defining the quality, safety, and consistency of the medicinal product throughout its lifecycle. The global push for innovative therapies targeting unmet medical needs has forced a radical departure from traditional, sequential development cycles. Modern drug discovery now demands parallel, risk-based workstreams where manufacturing strategies are initiated long before final proof-of-concept is achieved. By integrating rigorous analytical control with process chemistry and predictive formulation models, Creative Biolabs helps developers proactively mitigate risks associated with chemical instability, low solubility, or poor bioavailability early in the product lifecycle.
Our service portfolio is designed to be a comprehensive ecosystem for small molecule innovators. We offer:
Creative Biolabs provides small molecule process development and optimization, quantifying synthetic yields and purity profiles. We offer route scouting and scale-up to evaluate manufacturing feasibility.
Creative Biolabs provides small molecule analytical development and characterization, quantifying purity, stability, and structural identity. We offer method validation and physicochemical profiling to evaluate drug quality and structural integrity.
Creative Biolabs provides small molecule stability and degradation assessment, quantifying shelf-life and impurity profiles. We offer forced degradation and real-time testing to evaluate drug stability and molecular integrity.
Creative Biolabs provides small molecule manufacturing batch production and support, quantifying yield consistency and batch-to-batch reproducibility. We offer GMP-compliant scaling and process validation to evaluate production efficiency and product quality.
Eliminate Technical Uncertainty and Secure Your Material Supply — Request a Detailed Technical Proposal
To ensure a seamless transition from laboratory synthesis to large-scale production, Creative Biolabs follows a meticulously structured workflow.
Creative Biolabs stands out by integrating drug substance synthesis and drug product formulation under a single, unified management system, effectively eliminating the "knowledge gap" and logistical delays inherent in fragmented tech transfer. By housing chemistry, analytical, and formulation teams in a collaborative ecosystem, we ensure that critical insights, such as API hygroscopicity, thermal sensitivity, or polymorph stability, are communicated immediately to formulation scientists. Our experts utilize risk-based CMC frameworks to prioritize critical quality attributes (CQAs) from the very outset of development. This proactive foresight minimizes the risk of late-stage failures, ensuring your manufacturing process is optimized and "right the first time."
Leverage the Power of Unified CMC Oversight — Connect with Our Experts to Evaluate Your Lead Candidate's Manufacturability
We utilize specialized containment facilities and strict handling protocols designed for HPAPIs to ensure safety and prevent cross-contamination.
Yes, we provide phase-appropriate validation strategies that satisfy immediate safety requirements for early phases while building a roadmap for full commercial validation.
Our pre-formulation team employs various techniques, including micronization, amorphous solid dispersions, and salt selection to maximize oral bioavailability.
Creative Biolabs provides venom peptide synthesis, quantifying purity and structural identity. We offer chemical synthesis, recombinant production, and custom modifications to evaluate therapeutic potential and structural diversity.
Learn More →Creative Biolabs provides cell proliferation assessment, quantifying division, viability, and apoptosis. We utilize ATP assays, flow cytometry, and DNA replication markers to evaluate drug efficacy and immunomodulatory impact.
Learn More →Creative Biolabs provides a high-end, end-to-end platform for integrated small molecule CMC development and support services. From initial route scouting to batch manufacturing and regulatory dossier preparation, we ensure your molecule is robust, stable, and ready for the global stage.
Reach out today to transform your small molecule challenges into commercial successes and navigate the path to market with confidence.